CD7 and acute lymphoblastic leukemia: In a Phase I study of donor-derived CD5-CAR-T in patients with R/R T-ALL, 10 of 14 patients enrolled had CD7 negativity or low expression (including 7 post-CD7-CAR-T and 3 CAR-T-naive).